Kreitman, R., Wang, H., Colon, D. D., Arons, E., Zhou, H., Raffeld, M., Xi, L., Holly, E., James, L., Calvo, K., Maric, I., Yuan, C. (2025). Phase 2 trial of encorafenib plus binimetinib for patients with BRAF V600 mutated relapsed/refractory hairy cell leukemia. Blood. https://doi.org/10.1182/blood-2025-5683